BIOLIFE SOLUTIONS INC — Director's Dealing 2023

Nov 1, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-10-19

Reporting Person: Richardson Garrie (Chief Revenue Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	69007	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Award	$0		Common Stock (36320)		Direct

Footnotes

F1: The amount represented in Column 2 of Table I includes 69,007 shares of the Company's restricted stock granted on October 1, 2020 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments.

F2: The restricted stock was granted pursuant to the 2023 Omnibus Performance Incentive Plan. The restricted stock will vest 25% on the first anniversary of the grant date and thereafter annually in four equal installments. The restricted stock was granted to the reporting person as a part of their appointment to the position of Chief Revenue Officer.